Magnani H. on @ResearchGate about @NEJM @Boehringer RE-LY (#Pradaxa dabigatran) retraction #AllTrials

Thanks again Harry for your informed opinion on ResearchGate about this retraction & also for allowing me to share your comments in this chaotic blog. All the best wishes to you.

Note: retraction also available via figshare & twitter.

Any reason not to retract this paper  NEJM - RE-LY - Pradaxa - Dabigatran - Boehringer

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: